MAGE-B6 Inhibitors
MAGE-B6 inhibitors target various cellular mechanisms to reduce the functional activity of this protein. These inhibitors encompass a range of compounds that can disrupt protein synthesis, stability, and expression via different pathways. For instance, some chemicals exert their effects by binding to the ribosomal subunits, directly hindering the translational elongation process and leading to a decrease in MAGE-B6 protein levels. Others function by inhibiting the proteasome pathway, which is responsible for the degradation of polyubiquitinated proteins. This inhibition leads to the accumulation of defective proteins that induce stress responses, potentially reducing MAGE-B6 expression. Moreover, specific inhibitors can modify epigenetic marks; for example, by preventing the deacetylation of histones, they may change the chromatin structure and repress the transcription of genes including that which encodes MAGE-B6.
Furthermore, certain inhibitors interfere with DNA synthesis and repair mechanisms, affecting the expression of proteins such as MAGE-B6. Molecules that intercalate into DNA impede RNA synthesis, which could lead to a reduction in MAGE-B6 mRNA and subsequently its protein synthesis. Additionally, compounds that prevent the repair of damaged DNA may result in the downregulation of DNA damage-inducible proteins, including MAGE-B6. Other inhibitors target cellular stress responses, such as those inducing the unfolded protein response or altering the cellular autophagy pathway. By affecting the stability and degradation processes of proteins, these inhibitors can indirectly diminish the presence and activity of MAGE-B6.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
This compound binds to the E-site of the 60S ribosomal subunit, inhibiting translational elongation. MAGE-B6 protein synthesis is directly inhibited as a result, leading to decreased levels of the protein. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
As a proteasome inhibitor, this compound prevents the degradation of polyubiquitinated proteins, leading to the accumulation of defective proteins and inducing a cellular stress response that can downregulate the expression of proteins like MAGE-B6. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This histone deacetylase inhibitor increases the acetylation of histones, causing a change in chromatin structure that can lead to the repression of specific genes, including possibly the gene encoding MAGE-B6. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
An inhibitor of DNA methyltransferases, leading to hypomethylation of DNA and potentially affecting the expression of genes like MAGE-B6. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
By intercalating into DNA, this compound inhibits DNA-dependent RNA synthesis, potentially decreasing MAGE-B6 mRNA levels and thereby its protein expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
A Hsp90 inhibitor that can destabilize client proteins and lead to their degradation. Since Hsp90 is involved in the correct folding of many proteins, inhibition may result in reduced stability and expression of MAGE-B6. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
A steroidal lactone that has been shown to inhibit the proteasome pathway, which might lead to altered protein turnover and could affect the stability or expression of MAGE-B6. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
This compound accumulates in lysosomes, increasing their pH and inhibiting lysosomal enzymes. This could interfere with the autophagic degradation of proteins, potentially impacting MAGE-B6 levels. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A specific proteasome inhibitor that can lead to the accumulation of proteins destined for degradation, potentially affecting the levels of MAGE-B6. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can lead to the downregulation of protein synthesis pathways, potentially resulting in decreased expression of proteins like MAGE-B6. | ||||||